The Medicare value based purchasing initiative for hospitals is in full swing, and a number of other quality reporting and payment programs exist. Do they have an impact and how can they be maximized is the subject of a brief from the National Institute for Health Care Reform. (NIHCR Brief) The authors first discuss the proliferation of different measures and reports and the confusion that this can cause for payers and consumers in sorting out what is meaningful. They list several criteria for finding measures that should be considered important, including relevance to consumers to payers, validity in terms of really reflecting quality, accuracy and credibility of the results captured and the feasibility of collecting the data in an inexpensive and unobtrusive manner. Perhaps the biggest difficulty is finding measures that actually correlate with better health status and outcomes for patients. Structure, process and patient experience measures obviously do this less directly than actual outcomes. The source of data can also have a bearing on the accuracy of the measure and the cost of collecting and reporting it. Claims data, chart data, patient reported data and EHR data all have their limits. Chart data should be the most reliable, but unfortunately coding efforts aimed at higher reimbursement tend to afflict the accuracy of those as well in this era of reimbursement maximization consultants. And for many categories of patients or treatments, the number per year per hospital may be so small that statistical meaning is difficult to achieve. What is most striking is that although hospitals are already subject to the value based purchasing program, it is still not clear through solid research how much what is being measured and reported matters to ultimate quality, and it is very apparent that except for unusually informed and health literate consumers, most information is not easily assimilated by patients or even by payers.
✅ Subscribe via Email
About this Blog
Healthy Skeptic Podcast
Research
MedPAC 2019 Report to Congress
June 18, 2019
Headlines
Tags
Access
ACO
Care Management
Chronic Disease
Comparative Effectiveness
Consumer Directed Health
Consumers
Devices
Disease Management
Drugs
EHRs
Elder Care
End-of-Life Care
FDA
Financings
Genomics
Government
Health Care Costs
Health Care Quality
Health Care Reform
Health Insurance
Health Insurance Exchange
HIT
HomeCare
Hospital
Hospital Readmissions
Legislation
M&A
Malpractice
Meaningful Use
Medicaid
Medical Care
Medicare
Medicare Advantage
Mobile
Pay For Performance
Pharmaceutical
Physicians
Providers
Regulation
Repealing Reform
Telehealth
Telemedicine
Wellness and Prevention
Workplace
Related Posts
Commentary
Tim Walz Is an Idiot
March 20, 2025
Tim Walz Is an Idiot
Fat Timmy outdoes hisself again.
Commentary
Debunking Climate Hysteria, March 20, 2025
March 20, 2025
Debunking Climate Hysteria, March 20, 2025
The EPA's social cost of carbon analysis is of course found to be flawed, probably…
Commentary
A Good Longer-term Debt Auction
March 19, 2025
A Good Longer-term Debt Auction
A strong 20 year US debt auction.